Insomnia Update.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      INTELGENX Corp. ; SOMAXON Pharmaceuticals Inc.
    • Abstract:
      The article offers updates on pharmaceuticals for the treatment of insomnia. The drug delivery company IntelGenx Corp. has accomplished a biostudy on INT0020, a positive insomnia thin oral film, which explores the drug's bioequivalency to a branded product for treatment of insomnia. Somaxon Pharmaceuticals Inc. has obtained a U.S. patent entitled "Methods of Improving the Pharmacokinetics of Doxepin" which pertains to the dosing of Silenor (doxepin).